KDELR1 regulates chondrosarcoma drug resistance and malignant behavior through Intergrin-Hippo-YAP1 axis by Huabin Yin, Dongjie Jiang, Yongai Li, Wenjun Chen, Jie Zhang, Xinghai Yang, Jinbo Hu, Haifeng Wei

Get full text

Predictive value of near-term prediction models for severe immune-related adverse events in malignant tumor PD-1 inhibitor therapy by Yunyi Du, Ying Zhang, Wenqi Zhao, Yuexiang Zhang, Fei Su, Xiaoling Zhang, Weiling Li, Wenqing Hu, Yongai Li, Jun Zhao

Get full text

RAB3B Dictates mTORC1/S6 Signaling in Chordoma and Predicts Response to mTORC1‐Targeted Therapy by Jianxuan Gao, Jiali Jin, Runzhi Huang, Siqiao Wang, Sihui Song, Yu Zhang, Yongai Li, Jun Lin, Zhengyan Chang, Zongqiang Huang, Wei Sun, Huabin Yin, Dianwen Song, Jianru Xiao, Ping Wang, Tong Meng

Get full text

Immune repertoire sequencing reveals differences in treatment response to camrelizumab plus platinum-based chemotherapy in advanced ESCC by Xiaoling Zhang, Xiaoling Zhang, Xiaoling Zhang, Wenqi Zhao, Yunyi Du, Fei Su, Yuexiang Zhang, Hui Wang, Yongai Li, Min Liu, Yangjun Gao, Linlin Cai, Tingting Feng, Mei Wang, Chunmei Yao, Ning Xu, Yu Wang, Guohua Song, Guohua Song, Guohua Song, Wenqing Hu, Jun Zhao

Get full text